Status:
ACTIVE_NOT_RECRUITING
Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Cancer
Cancer, Metastatic
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to examine the relationships between objectively measured physical activity and provider-assessed and patient-reported functional outcomes in patients with advanced cancer...
Detailed Description
Patients diagnosed with stage 3/ 4 cancer will be enrolled. After providing informed consent, patients will be asked to wear a FitBit Charge HR continuously for 8 weeks with the option to continue wea...
Eligibility Criteria
Inclusion
- Diagnosis of advanced (stage 3 or 4) cancer of any type
- Ambulatory (use of walking aids, such as cane and rollator, is acceptable)
- Access to a device that has the capability to sync to the Fitbit
- Expected to have standard of care oncology appointments at least once every 8 weeks (+/-7 days).
- Have an understanding, ability, and willingness to fully comply with study procedures and restrictions
- English or Spanish speaking
- Ability to consent
- Informed consent obtained from subject and ability for subject to comply with the requirements of the study.
Exclusion
- Allergy to surgical steel or elastomer/rubber
- Using a pacemaker, implantable cardiac defibrillator, neurostimulator, implantable hearing aids, cochlear implants, or other electronic medical equipment. However, removable hearing aids are permitted.
Key Trial Info
Start Date :
December 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03757182
Start Date
December 5 2018
End Date
December 31 2024
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048